The Use of a Telehealth Model Provides Timely Access to Allogeneic Hematopoietic Cell Transplantation (alloHCT) Consultation and Preliminary Donor Search for Patients with Hematologic Malignancies at the Only Allohct Center in the State.
Chelsea Bowman(Oregon Health & Science University), Arpita Gandhi(Oregon Health & Science University), Eneida R. Nemecek(Oregon Health & Science University), Jessica Leonard(Oregon Health & Science University), Jennifer N. Saultz(Oregon Health & Science University), Gabrielle Meyers(Oregon Health & Science University), Amrita Desai(Oregon Health & Science University), Richard T. Maziarz(Oregon Health & Science University), Rachel J. Cook(Oregon Health & Science University), Mrs. Kelli Goslee(Oregon Health & Science University), Brandon Hayes‐Lattin(Oregon Health & Science University), Claire Irvan(Oregon Health & Science University), Victoria Orozco(Oregon Health & Science University)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577